Wenjian Ju

Title: The Innovations of Wenjian Ju

Introduction

Wenjian Ju is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of selective inhibitors for protein kinases. His work is crucial in the fight against proliferative disorders, including cancer.

Latest Patents

Wenjian Ju holds a patent for a tartrate of a selective CDK9 inhibitor and its crystal form. This patent, which is aimed at treating diseases related to protein kinase/CDK activity, showcases his innovative approach to addressing critical health issues. The specific compound disclosed in the patent is 3-(5-fluoro-4-(4-methyl-2-(methylamino)thiazol-5-yl)pyrimidin-2-ylamino)-benzenesulfonamide, which has shown promise in inhibiting cyclin-dependent kinase 9 (CDK9).

Career Highlights

Throughout his career, Wenjian Ju has worked with prominent companies in the biopharmaceutical sector. Notable among these are Changzhou Qianhong Biopharma Co., Ltd. and Changzhou Le Sun Pharmaceuticals Limited. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in drug development.

Collaborations

Wenjian Ju has collaborated with esteemed colleagues, including Shudong Wang and Hui Wang. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Wenjian Ju's contributions to the field of biopharmaceuticals, particularly through his patent for a selective CDK9 inhibitor, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of serious health conditions.